Newsfile Corp
07 Jun 2026, 20:16 UTC · 18h ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
Newsfile Corp
07 Jun 2026, 20:16 UTC · 18h ago
Story key points
2 claims · impact-rated
Culper Research released a report alleging that ADMA Biologics engaged in channel stuffing to inflate revenue growth. — Allegations of financial fraud and revenue manipulation are severe and typically lead to significant stock price depreciation and loss of investor trust.
-0.80The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit against ADMA Biologics for allegedly issuing misleading business information. — The formalization of a class action lawsuit increases the likelihood of legal settlements and financial liabilities for the company.
-0.50Ticker attribution
Model heads
The company is facing a securities class action investigation following allegations of channel stuffing to inflate revenue.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is mentioned in the context of a securities class action lawsuit regarding investor losses.
The company is mentioned in the context of a securities class action lawsuit.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Newsfile Corp
5h ago
